Related Experiment Video
Updated: May 15, 2026
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
The clinical ramifications of polycystic ovarian morphology in oocyte donors
M Cho1, G Ambartsumyan, H Danzer
1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of California-Los Angeles, CA, USA. michele.cho@gmail.com
Objective:
To determine the relationship between Polycystic Ovary (PCO) morphology and In Vitro Fertilization (IVF) outcome in oocyte donation cycles.
Design:
Cross sectional study
Setting:
Private IVF clinic
Patients:
164 consecutive ovum donors and their recipients were reviewed, 149 were included in the study where 113 patients had normal ovarian morphology and 36 patients had PCO morphology.
Interventions:
All donors underwent ovarian stimulation in conjunction with GnRH agonist or antagonist in standard fashion.
Main Outcome Measures:
Baseline donor characteristics were recorded, as well as details of IVF stimulation and embryo data. Recipient data on pregnancy and miscarriage were also collected.
Results:
Patients with PCO ovaries had significantly higher peak estradiol levels and required less gonadotropins during IVF stimulation. In addition, the baseline characteristics between donor groups did not differ except for ovarian morphology. The number of oocytes retrieved and indicators of embryo quality did not differ between the two groups, and there was no significant difference between pregnancy and miscarriage rates in the recipients.
Conclusions:
Oocyte donors with PCO morphology have equivalent pregnancy rates and do not need to be excluded as potential donors.
